Clinical Trial Update: A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Lebrikizumab in adults with perennial allergic rhinitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Perennial Allergic Rhinitis (PAR) | Phase 3 | Status: RECRUITING